Document is current
Any future updates will be listed below
-
Authors
Li, Ye
Deng, Jingjing
Jian, Yuan
Zhang, Zhiyao
Chen, Wenming
-
Funding
Funding for this research was provided by:
the establishment and application of a detection method for minimal residual disease in multiple myeloma based on second-generation sequencing technology (YGLX202309)
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 10 January 2025
First Online: 6 February 2025
Declarations
:
: This study was approved by the Medical Ethics Committee of Beijing Chaoyang Hospital. We followed patients through an electronic medical record system without disturbing them in any way or interfering with their treatment. Informed consent was not required because the data were anonymized.
: The authors declare no competing interests.
